Nicola Giesen

Stuttgart, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis.

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis.

Journal: Journal of hematology & oncology

Published: April 06, 2026

30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Journal: Annals of hematology

Published: April 02, 2026

Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study.

Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study.

Journal: Infection

Published: March 10, 2026

Seasonal community-acquired respiratory virus infections in patients with cancer-Epidemiological and clinical overview, an analysis of the multicenter OncoReVir registry.

Seasonal community-acquired respiratory virus infections in patients with cancer-Epidemiological and clinical overview, an analysis of the multicenter OncoReVir registry.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 24, 2025

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO).

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO).

Journal: Annals of hematology

Published: October 24, 2025

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

Journal: The Lancet. Oncology

Published: October 21, 2025

Respiratory syncytial virus-not only relevant for hygienic reasons

Respiratory syncytial virus-not only relevant for hygienic reasons

Journal: Innere Medizin (Heidelberg, Germany)

Published: June 17, 2025

Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer.

Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer.

Journal: Oncology research and treatment

Published: June 02, 2024

Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study.

Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study.

Journal: Vaccines

Published: April 23, 2024

Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma.

Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma.

Journal: European journal of haematology

Published: February 28, 2024

Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation.

Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: January 28, 2024

Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.

Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.

Journal: Blood

Published: January 17, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026